On November 28, the "National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Pharmaceutical Catalog (2024)" was officially announced. Three innovative drugs from Sanofi are included, namely Dupixent (dupilumab injection) successfully renewed, Breezhaler (breztri oral tablets), and Zhilida (rosuvastatin and ezetimibe tablets (I)) for the first time included in the insurance catalog. The adjusted new version of the medical insurance pharmaceutical catalog will be officially implemented on January 1, 2025.
赛诺菲三款创新药进入2024年国家医保目录
Sanofi's three innovative drugs will enter the national medical insurance catalog in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated